Financial Performance - In 2024, the company's annual revenue was 1,791.04 million yuan, an increase of 2.18% year-on-year [3] - The net profit attributable to shareholders, excluding non-recurring gains and losses, was 220.83 million yuan, up 32.07% year-on-year [3] - In Q1 2025, revenue was 412.21 million yuan, a decrease of 16.47% year-on-year, while net profit attributable to shareholders increased by 102.34% to 75.94 million yuan [3] Cash Management Strategies - The company maintains liquidity through two strategies: optimizing the operating cycle by shortening accounts receivable periods and extending accounts payable periods, and replacing low-interest debt to optimize the debt structure [3] - The cash reserves will be used based on business development needs, including potential mergers, production expansion, or R&D [3] Product Development and Market Expansion - The company has achieved significant results in the lactose derivatives field, with products like 2'-FL and LNT receiving Self-GRAS certification in the U.S. [3] - These products are gradually entering the U.S. and other international markets, but have not yet significantly contributed to revenue growth [3] Share Buyback and Market Confidence - The completion of the share buyback plan signals that the company's value is underestimated, which may enhance investor confidence [4] - The management believes the current stock price does not reflect the company's intrinsic value and growth potential [4] Accounts Receivable Management - The company's accounts receivable mainly consist of government waste treatment fees, primarily from first-tier cities, with a low likelihood of loss [4] - The company actively manages and collects accounts receivable to avoid cash flow and profitability issues [4] Future Outlook and Strategic Initiatives - For 2025, the company plans to enhance operational efficiency and strategic layout while balancing current performance and long-term development [6] - The company will continue to invest in R&D and project expansion, particularly in synthetic biology, to ensure steady progress in core technology and market development [6] International Expansion Challenges - The Singapore subsidiary has faced delays in fund approval for outbound investment, but there are no safety concerns regarding funds [6] - The company is committed to enhancing communication with shareholders regarding any shareholding changes and market strategies [6] Production Capacity and Project Updates - The first phase of the 1,000-ton HMO production facility is expected to begin trial production in the first half of 2025, with the second phase projected for 2026 [9] - The company is actively expanding its market presence for its HMO products, aligning with market demand forecasts [9]

Investment Rating - The report maintains a positive outlook on the power and natural gas sectors, indicating a favorable investment environment for renewable energy and gas companies [2][10]. Core Insights - The Shandong provincial government has introduced its first local guidelines for the marketization of renewable energy pricing, which is expected to stabilize returns for existing projects and provide a model for other provinces [5][7]. - Global natural gas prices have seen a slight rebound due to tightening supply and increased demand for LNG exports, with specific price movements noted in various regions [10][19]. - The report highlights the potential for LNG import prices to decrease further in the second half of 2025, benefiting downstream gas companies [11][29]. Summary by Sections 1. Power Sector: Shandong's New Energy Market Guidelines - Shandong's new energy pricing reform outlines that existing projects will participate in market pricing at a rate of 0.3949 yuan per kWh, aligning with the provincial coal benchmark price [5][6]. - The guidelines emphasize strong connectivity with existing policies, ensuring stability for existing projects while introducing competitive elements for new projects [6][7]. - The implementation of these guidelines is expected to serve as a model for other provinces, enhancing the operational efficiency and market strategies of renewable energy companies [7][8]. 2. Natural Gas: Global Demand and Price Rebound - As of May 9, 2025, the Henry Hub spot price in the U.S. was $3.22/mmBtu, reflecting a weekly increase of 3.84%, while European prices also saw a rise due to supply constraints and seasonal demand [10][19]. - The report notes that the overall LNG import cost in China has remained below 4000 yuan per ton, with a significant decrease of 18.4% from the year's peak [11][29]. - The anticipated decline in international oil prices is expected to further lower LNG import prices in China, benefiting city gas companies [11][29]. 3. Weekly Market Review - The public utilities, environmental protection, power equipment, and gas sectors outperformed the Shanghai and Shenzhen 300 index during the review period [35]. 4. Company and Industry Dynamics - Recent developments include the issuance of competitive configuration announcements for renewable energy projects in various provinces, indicating ongoing investment and growth in the sector [44][46]. - The report also highlights significant corporate announcements, including financing and profit distribution plans from key players in the energy sector, reflecting a proactive approach to capital management and shareholder returns [48][49].

证券代码：301305 证券简称：朗坤科技 公告编号：2025-041 关于举行 2024 年度网上业绩说明会的公告 深圳市朗坤科技股份有限公司（以下简称"公司"）已于 2025 年 4 月 25 日披露了《2024 年年度报告》，为使投资者进一步了解公司的财务状况、经营 情况及公司发展规划，公司将于 2025 年 5 月 14 日（星期三）15:30-16:30 在全 景网举行 2024 年度网上业绩说明会。本次说明会将采用网络远程方式举行，投 资者可登录全景网"投资者关系互动平台"（http://ir.p5w.net）参与本次业绩说 明会。 出席本次业绩说明会的人员有：董事长兼总经理陈建湘，董事、副总经理 周存全，财务总监丰绍明，董事会秘书严武军，独立董事陈慈琼，保荐代表人 王玉亭（具体以实际参会人员为准）。为充分尊重投资者，提升交流的针对 性，现就公司 2024 年度网上业绩说明会提前向投资者公开征集问题，广泛听取 投资者的意见和建议。投资者可于 2025 年 5 月 13 日（星期二）17:00 前访问 http://ir.p5w.net/zj/，进入问题征集专题页面进行提问。公司将在本次年度业绩 说 ...

证券代码：301305 证券简称：朗坤科技 公告编号：2025-040 深圳市朗坤科技股份有限公司 关于注销募集资金现金管理专用结算账户的公告 | 1 | 深圳市朗坤科技股份有限 | 中国建设银行股份有限公 | 44050169101100000890 | | --- | --- | --- | --- | | 序号 | 账户名称 公司 | 开户银行名称 司茂名高州光明支行 | 银行账号 | 深圳市朗坤科技股份有限公司董事会 2025 年 4 月 28 日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 深圳市朗坤科技股份有限公司（以下简称"公司"）于 2024 年 4 月 17 日召 开第三届董事会第十六次会议、第三届监事会第八次会议，2024 年 5 月 10 日召 开 2023 年年度股东大会，审议通过了《关于使用部分闲置募集资金进行现金管 理的议案》。在不影响募集资金投资项目建设的情况下，使用总额不超过 5.65 亿 元的闲置募集资金（含超募资金）进行现金管理，购买包括但不限于结构性存款、 大额存单等安全性高、流动性好，期限最长不超过 12 个月（可 ...

Core Insights - The company reported a significant increase in net profit and improved cash flow, driven by new project wins and stable operational growth [2] - The company achieved a revenue of 1.791 billion yuan in 2024, a 2% year-on-year increase, and a net profit of 216 million yuan, a 21% increase [1][2] - In Q1 2025, the company reported a revenue of 412 million yuan, a 16% year-on-year decline, but a net profit of 77 million yuan, a 95% increase [1][2] Revenue Breakdown - Engineering construction revenue reached 418 million yuan, a 138% year-on-year increase, with a gross margin of 17.72%, down 1.82 percentage points [2] - Operational services generated 581 million yuan, a 9% year-on-year increase, with a gross margin of 41.43%, down 0.47 percentage points [2] - Bioenergy revenue was 786 million yuan, a 19% year-on-year decline, but the gross margin improved by 9.12 percentage points to 27.44% [2] Cash Flow Improvement - Operating cash flow significantly improved, reaching 391 million yuan, a 246% year-on-year increase [2] Environmental Projects - The company has 35 biomass resource regeneration projects, with 21 already operational [3] - New major environmental project wins include a 1.654 billion yuan biomass waste resource processing center in Beijing and a 736 million yuan biomass resource regeneration center [3] Synthetic Biology Developments - The company made significant progress in the field of human milk oligosaccharides (HMOs), achieving industry-leading product purity [4] - Regulatory approvals for LNnT and LNT have been obtained, with production capacity expected to ramp up in the coming years [4] Profit Forecast - Revenue projections for 2025-2027 are 2.293 billion, 2.882 billion, and 3.625 billion yuan, with year-on-year growth rates of 28.03%, 25.68%, and 25.81% respectively [5] - Net profit forecasts for the same period are 319 million, 436 million, and 599 million yuan, with growth rates of 48.19%, 36.63%, and 37.24% respectively [5]

Core Viewpoint - Longkun Environment has achieved significant performance growth and strategic breakthroughs in the fields of biomass resource regeneration and synthetic biology manufacturing, as evidenced by its latest financial report. Financial Performance - In 2024, Longkun Environment reported total revenue of 1.791 billion yuan, a year-on-year increase of 2.18%; net profit reached 216 million yuan, up 20.51% [1] - In Q1 2025, the company achieved revenue of 412 million yuan and a net profit attributable to shareholders of 76.843 million yuan, marking a year-on-year growth of 94.77%; the non-recurring net profit saw a growth of 102.34% [1][2] Biomass Resource Regeneration Business - Longkun Environment is a leading enterprise in the domestic biomass waste resource utilization sector, utilizing core technologies such as microbial technology and enzyme methods to convert waste into biodiesel and green electricity [2] - In Q1 2025, the biomass resource regeneration business generated revenue of 412 million yuan, with a net profit of 76.843 million yuan, reflecting a year-on-year increase of 94.77% [2] - The company operates over 30 biomass resource regeneration centers nationwide, with five projects having a daily processing capacity exceeding 1,000 tons, covering major cities like Beijing and Shenzhen [2] - The company secured several major projects in 2024, including a 25.5 million yuan project for kitchen waste treatment in Beijing and a 1.654 billion yuan biomass treatment center project in Tongzhou District [2] Synthetic Biology Manufacturing Business - In the synthetic biology manufacturing sector, Longkun Environment targets the billion-yuan market for human milk oligosaccharides (HMOs) and accelerates industrialization through partnerships with research institutions [3] - The company has made significant progress in product certification, with LNT and LNnT completing the domestic health committee's opinion collection, and LNnT receiving approval as a new food additive [3] - The applications of HMOs span infant formula, adult food, functional food, and nutritional supplements, indicating a broad potential market [3] Strategic Upgrade and Rebranding - On October 31, 2024, Longkun Environment officially initiated a brand upgrade, changing its name to Shenzhen Longkun Technology Co., Ltd, reflecting a strategic shift towards technology empowerment [4] - The name change aims to enhance the company's brand recognition in emerging sectors such as synthetic biology and biomass energy, laying the foundation for expanding into international high-value markets [4]

1、首次授予部分符合归属条件的激励对象人数共计 83 人，预留授予部分符 合归属条件的激励对象人数共计 8 人（其中 2 人为追加授予）。 2、首次授予部分拟归属数量为 96.90 万股，占公司当前总股本的比例为 0.40%；预留授予部分拟归属数量为 7.20 万股，占公司当前总股本的比例为 0.03%。 证券代码：301305 证券简称：朗坤环境 公告编号：2025-023 深圳市朗坤科技股份有限公司 关于公司2023年限制性股票激励计划首次及预留授予部分 第一个归属期归属条件成就的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 重要内容提示： 3、限制性股票归属价格（调整后）：9.33 元/股 4、股票来源：公司向激励对象定向发行的本公司人民币 A 股普通股股票 5、本次归属的限制性股票在相关手续办理完成后、上市流通前，公司将发 布相关提示性公告，敬请投资者注意。 深圳市朗坤科技股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日召 开的第三届董事会第二十二次会议、第三届监事会第十三次会议，审议通过了《关 于公司 2023 年限制性股 ...

证券代码：301305 证券简称：朗坤环境 公告编号：2025-022 深圳市朗坤科技股份有限公司 关于作废公司2023年限制性股票激励计划部分已授予尚未 归属的限制性股票的公告 监事会对本次激励计划授予激励对象名单及授予数量的调整事项以及对该 授予日的激励对象名单进行核实，认为其作为本次激励计划的激励对象的主体资 格合法、有效。 （6）2024 年 10 月 24 日，公司召开第三届董事会第二十次会议、第三届监 事会第十二次会议，审议通过了《关于调整 2023 年限制性股票激励计划授予价 格的议案》《关于向 2023 年限制性股票激励计划激励对象授予剩余预留限制性 股票的议案》等议案，本次激励计划限制性股票授予价格由 9.43 元/股调整为 9.33 元/股，并同意以 2024 年 10 月 24 日为剩余预留限制性股票授予日，以 9.33 元/ 股的授予价格向符合授予条件的 2 名激励对象授予 6 万股第二类限制性股票，监 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 深圳市朗坤科技股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日召 ...

我们审计了深圳市朗坤科技股份有限公司（以下简称朗坤科技公司）财务报 表，包括 2024 年 12 月 31 日的合并及母公司资产负债表，2024 年度的合并及母 公司利润表、合并及母公司现金流量表、合并及母公司所有者权益变动表，以及 相关财务报表附注。 目 录 审 计 报 告 天健审〔2025〕3-259 号 深圳市朗坤科技股份有限公司全体股东： | 一、审计报告……………………………………………………………第 | 1—6 | 页 | | --- | --- | --- | | 二、财务报表…………………………………………………………第 | 7—14 | 页 | | （一）合并资产负债表………………………………………………第 | | 7 页 | | （二）母公司资产负债表……………………………………………第 | | 8 页 | | （三）合并利润表……………………………………………………第 | | 9 页 | | （四）母公司利润表…………………………………………………第 | | 10 页 | | （五）合并现金流量表………………………………………………第 | | 11 页 | | （六）母公司现金流量表…… ...

三、附件……………………………………………………………第 14—17 页 （一）本所执业证书复印件………………………………………第 14 页 （二）本所营业执照复印件………………………………………第 15 页 （三）本所注册会计师执业证书复印件……………………第 16—17 页 募集资金年度存放与使用情况鉴证报告 天健审〔2025〕3-261 号 目 录 一、募集资金年度存放与使用情况鉴证报告………………………第 1—2 页 二、关于募集资金年度存放与使用情况的专项报告…………… 第 3—13 页 一、对报告使用者和使用目的的限定 本鉴证报告仅供朗坤科技公司年度报告披露时使用，不得用作任何其他目的。 我们同意将本鉴证报告作为朗坤科技公司年度报告的必备文件，随同其他文件一 起报送并对外披露。 二、管理层的责任 朗坤科技公司管理层的责任是提供真实、合法、完整的相关资料，按照《上 市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年 修订）》（证监会公告〔2022〕15 号）和《深圳证券交易所上市公司自律监管 指引第 2 号——创业板上市公司规范运作（2023 年 12 月修订）》（深证上 ...